Epidemiologist at Datamonitor Healthcare. Views expressed are my own.

Joined June 2015
Charlotte Huntley retweeted
Landmark Malaria Vaccine Pilot Launches In Malawi bit.ly/2IT2tdU #PinkSheet
1
2
Download our whitepaper & discover how pharmaceutical manufacturers' success will require increasing flexibility on price & the ability to adapt to new access scenarios. Get your copy here: bit.ly/2IHIDSr
1
1
Future Of Cardio And Mental Health Will Be Defined By Digital Advances Cardiovascular diseases are responsible for 30% of worldwide deaths, and about 25% of the global population experiences mental illness each... Related Stories Pharma Told bit.ly/2SuNb07 #InVivo
2
2
Charlotte Huntley retweeted
Entries are now open for the 14th Annual Scrip Awards! Over the past 14 years, the Scrip Awards has sought to applaud the essential role that the #pharmaceutical, #biotech and other allied industries play in improving #healthcare. Enter here: bit.ly/2Hp6Rkp
2
1
Learn more about the key challenges and opportunities facing the #HIV Market in our #Webinar presented by @datamonitor_MH & #JosephHaas on the 19th April. Register here: bit.ly/2tswPOf #aids #HIVstrategy #Hematology #AIDS #hivtrials #hivawareness #Tivicay
3
2
Charlotte Huntley retweeted
Show your rare, show you care! There’s a new way to get involved in Rare Disease Day 2018! How? Paint your face to show your support for the rare disease community and share your selfie on social media during February including #ShowYourRare Find out more rarediseaseday.org/article/s…
1
81
6
95
Charlotte Huntley retweeted
Scrip 100 Numbers Crunched. Who is leading the way? scrip.pharmaintelligence.inf… #pharma #infographic #bigpharma #biotech #Scrip100
5
2
Charlotte Huntley retweeted
UPenn's first human clinical trial in #CRISPR could be starting soon: bit.ly/2rpbwfx; studies in multiple myeloma, sarcoma, and melanoma
3
2
Charlotte Huntley retweeted
Be sure to check out this webinar on January 31 with what are sure to be great insights on the #dyslipidemia market from @datamonitor_JA xitter.cf/Pharma_Intell/status/9…
Join presenter Jack Allen as he uses the exclusive data from @Biomedtracker and @Datamonitor_HC to look at the upcoming projected market for #dyslipidemia: bit.ly/2m88qGH
7
1
Charlotte Huntley retweeted
$SGMO many partners interested in their allo CAR-T capabilities and looking to enter partnership in this field in the early part of 2018
2
5
1
13
Charlotte Huntley retweeted
5/5 - #JPM18 $SGMO - announcement of oncology partner in early 2018; SB-525 hemophilia A H1 2018; ST-400 data in mid-2018, build out internal manufacturing facility in SF
3
5
Charlotte Huntley retweeted
This Market Spotlight report covers the #ThyroidCancer market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events and more: bit.ly/2B6Bet3
1
1
Charlotte Huntley retweeted
Have you read our blog post about making a pledge for more veg? #FoodPolicy ow.ly/ZVRZ30gKK5t
3
4
Charlotte Huntley retweeted
Are you planning an event for #RareDiseaseDay 2018? You can spread the word by adding it to our interactive map! rarediseaseday.org/events/wo…
1
19
3
35
Charlotte Huntley retweeted
CAR-T @icer_review concludes that given the evidence available Kymriah $NVS and Yescarta $GILD seem to be priced in alignment with clinical benefit Positive report for CAR-T as they enter negotiations with insurers in the new year $JUNO $CLLS $BLCM $ZIOP $BLUE $CELG $PFE
8
8
Charlotte Huntley retweeted
Regeneron On Genetics R&D: 'It's Our Oxygen' scrip.pharmaintelligence.inf…
Charlotte Huntley retweeted
Extremely defensive play from $BIIB to acquire ALKS 8700, but probably the best way for them to spend $ in MS right now. Seems cheap for $ALKS, who is now relying on Biogen's commitment to provide royalty stream.
4
8